FGFR2 and acute myeloblastic leukemia with maturation: Accumulating evidences indicated that several signalling pathway‐related mutations including BRAFV600E, RAS, FGFR2, and SMO were synergistically contributed to the AM progression.24, 25, 26, 27, 28